Advencis

Advencis launched a modular system of early detection, fully automated for industrial microbiology (food and pharmaceutical industries) and clinical markets. The system provides highly sensitive detection of the microorganisms on agar plates and on filter-based devices.

On October 15, 2014, bioMérieux acquired the entire capital of Advencis.